Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
01/2009
01/08/2009WO2008100244A3 Methods of detecting mutations associated with ataxia-ocular apraxia 2 (aoa2)
01/08/2009WO2008094194A3 Pkd mutations and evaluation of same
01/08/2009WO2008091659A3 Methods and compositions for predicting and treating drug resistant strains of influenza virus
01/08/2009WO2008090340A3 Nucleic acid amplification and testing
01/08/2009WO2008087035A3 Screening method for anti-diabetic compounds
01/08/2009WO2008082730A3 Biomarkers of target modulation, efficacy, diagnosis and/or prognosis for raf inhibitors
01/08/2009WO2008074346A3 Chimeric dna polymerase
01/08/2009WO2008070311A3 Gene expression profiling of parkinson's disease
01/08/2009WO2008039998A3 Methods for sequencing dna
01/08/2009WO2008008155A3 Small molecule modulators of p53 family signaling
01/08/2009WO2007128004A3 Methods, compositions, and kits for detecting protein aggregates
01/08/2009WO2007117680A3 Methods and compositions for treating bacterial infection
01/08/2009WO2007089303A9 Methods and compositions for diagnosing ankylosing spondylitis using biomarkers
01/08/2009WO2006104035A9 Tripodal functional interface molecule for immobilization of biological molecule and device for detection of gene
01/08/2009WO2005080595A3 Gene cloning method
01/08/2009US20090013435 Clostervirus-resistant melon plants
01/08/2009US20090013431 Stress tolerant cotton plants
01/08/2009US20090013421 Genomic DNA fragments containing regulatory and coding sequences for the B2-subunit of the neuronal nicotinic acetylcholine receptor and transgenic animals made using these fragments or mutated fragments
01/08/2009US20090013420 Psmcs as Modifiers of the Rb Pathway and Methods of Use
01/08/2009US20090013416 Pdes as modifiers of the igfr pathways and methods of use
01/08/2009US20090012716 Diabetes-related biomarkers and methods of use thereof
01/08/2009US20090012371 Genetic markers of schizophrenia
01/08/2009US20090012136 Unit dose formulations and methods of treating and preventing thrombosis with thromboxane receptor antagonists
01/08/2009US20090012130 Strategies for Designing Drugs that Target the Sir2 Family of Enzymes
01/08/2009US20090012113 Administering rifaximin to the subject
01/08/2009US20090012053 Use of LXR agonists for the treatment of osteoarthritis
01/08/2009US20090012048 Methods for diagnosing and treating a mycobacterium avium subspecies paratuberculosis infection
01/08/2009US20090012038 Methods for microbial biofilm destruction and interference with microbial cellular physiology
01/08/2009US20090012033 Delivery of Biologically Active Materials Using Core-Shell Tecto(Dendritic Polymers)
01/08/2009US20090012026 Association Between the Tdoa Gene and Osteoarthritis
01/08/2009US20090012024 Stem Cell Markers
01/08/2009US20090012022 Hybrid Interfering Rna
01/08/2009US20090012020 Inhibiting formation of atherosclerotic lesions
01/08/2009US20090012017 Polypeptide Complex that Regulates Cell Cycle and Anergy
01/08/2009US20090012003 Polypeptides homologous to vegf and bmp1
01/08/2009US20090011996 Diagnosing and protecting horses against papillomavirus
01/08/2009US20090011995 Production of a soluble native form of recombinant protein by the signal sequence and secretional enhancer
01/08/2009US20090011989 Treating or preventing myocardial contractile dysfunction that occurs after a myocardial infarction or other structural heart disease (e.g., end-stage valve disease) by by administering CaMK11 inhibitor, a peptide having a specific sequence of amino acids; dilated cardiomyopathy; transgenic animals
01/08/2009US20090011983 186 Human Secreted Proteins
01/08/2009US20090011959 Method for preparing single-stranded DNA libraries
01/08/2009US20090011955 Method for Localization of Nucleic Acid Associated Molecules and Modifications
01/08/2009US20090011950 Method for detecting oral squamous-cell carcinoma and method for suppressing the same
01/08/2009US20090011943 High throughput genome sequencing on DNA arrays
01/08/2009US20090011511 Single-Point Genome Signature Tags
01/08/2009US20090011487 Production of UGPPase
01/08/2009US20090011468 Method for improving protein production
01/08/2009US20090011458 Method for selectively staining microorganisms
01/08/2009US20090011457 Method and device for testing the bactericidal effect of substances
01/08/2009US20090011456 Methods for the Diagnosis and Prognosis of Graft Versus Host Disease By Measurement of Peripheral Cd3+Cd4+Cd8Beta+ Cells
01/08/2009US20090011455 Disease model incorporation into an artificial immune system (ais)
01/08/2009US20090011454 Fluorescent Sensors for Cellular Amines
01/08/2009US20090011453 Methods for Producing Proteins Using Hamster Igf-1
01/08/2009US20090011452 Method of Prognosis of Mental Diseases, E.G. Autism and Cerebral Palsy
01/08/2009US20090011451 Microfluidic device and leucocyte antigen mediated microfluidic assay
01/08/2009US20090011450 Dry analytical element for lipase measurement
01/08/2009US20090011449 No calibration analyte sensors and methods
01/08/2009US20090011448 nonspecific reactions in the Limulus reaction can be inhibited conveniently, quickly, inexpensively and effectively; increased accuracy
01/08/2009US20090011447 Quantification of vitellogenin
01/08/2009US20090011446 Colony assay miniaturization with enumeration output
01/08/2009US20090011445 Method and apparatus for in vivo collection of circulating biological components
01/08/2009US20090011440 Receptor Tyrosine Kinase Signaling Pathway Analysis For Diagnosis And Therapy
01/08/2009US20090011438 identifying hyperplasia in a tissue by identifying epithelial cells of the tissue that have more surface-bound collagen VI alpha 3 carboxy-terminus than full length collagen VI protein; determining whether a cancer is progressing by measuring surface-bound collagen VI alpha 3
01/08/2009US20090011436 Dry Chemistry, Lateral Flow-Reconstituted Chromatographic Enzyme-Driven Assays
01/08/2009US20090011434 Methods And Compositions For Diagnosing Breast Cancer
01/08/2009US20090011432 Detecting and Profiling Molecular Complexes
01/08/2009US20090011431 Diagnosis of Sepsis by the Selective Determination of the Concentration of Cu/Zn Superoxide Dismutase (Cu/Zn Sod) in Patient Samples
01/08/2009US20090011424 Cancer-suppressing agents
01/08/2009US20090011423 Genes for prognosis of cancer
01/08/2009US20090011422 Methods for cloning small rna species
01/08/2009US20090011421 Susceptibility to bone damage
01/08/2009US20090011420 Dissolved in an aqueous buffer to form solutions with moderate to high viscosity; use in the electrophoretic separation of nucleic acids
01/08/2009US20090011419 Probe, probe set, probe carrier, and testing method
01/08/2009US20090011418 Functional toll-like receptors (tlr) on melanocytes and melanoma cells and uses thereof
01/08/2009US20090011417 Testing Device
01/08/2009US20090011416 Random array DNA analysis by hybridization
01/08/2009US20090011415 Regulation of neuronal expression of apolipoprotein e
01/08/2009US20090011414 Human autism susceptibility gene encoding a kinase and uses thereof
01/08/2009US20090011413 Method for screening colon cancer cells and gene set used for examination of colon cancer
01/08/2009US20090011412 Using huntingtin Interacting Protein 1 (HIP1) expression profiles as evaluative tools in diagnosis and treatment of lymphoma and brain cancers
01/08/2009US20090011411 Method for Detecting and Quantifying Endogenous Wheat Dna Sequence
01/08/2009US20090011410 Method for tailoring administration of drugs by quantitation of mrna
01/08/2009US20090011409 Antibodies Against Cells of Fetal Origin
01/08/2009US20090011408 Generating a signal indicative of the presence of a target nucleic acid in a sequence by incubating the sample containing the target with a reverse transcriptase, a primer and a probe
01/08/2009US20090011407 Polymorphic Cd24 Genotypes that are Predictive of Multiple Sclerosis Risk and Progression
01/08/2009US20090011406 Method of Judging Fatigue
01/08/2009US20090011405 Modulating Screening Thresholds for N-Hybrid Screening
01/08/2009US20090011404 Methods and compositions for optical detection of single-stranded polynucleotides
01/08/2009US20090011403 Microporous materials, methods of making, using, and articles thereof
01/08/2009US20090011402 Detecting an effector or cofactor aggregate; nucleic acid enzyme and polynucleotide substrate;first set of particles comprising a second polynucleotide complementary to substrate; second set of particles comprising a third polynucleotide complementary to substrate; tail-to-tail hybridization
01/08/2009US20090011401 Group of reagent carriers that is combined to form a composite
01/08/2009US20090011400 Substrate switched ammonia lyases and mutases
01/08/2009US20090011080 Gene encoding protein responsible for flocculation property of yeast and use thereof
01/08/2009US20090011049 Methylation Markers for Prognosis and Treatment of Cancers
01/08/2009US20090010955 Vaccines Containing Canine Parvovirus Genetic Variants
01/08/2009US20090010953 Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods
01/08/2009US20090010951 Epitope/Peptide Recognized By Hla-A2402-Restricted Ep/Cam-Specific Ctl And Use Of The Same
01/08/2009US20090010950 Ex-vivo isolated cd25+cd4+ t cells with immunosuppressive activity and uses thereof
01/08/2009US20090010943 Peptides associated with HLA-DR MHC class II molecule and involved in Rheumatoid arthritis
01/08/2009US20090010942 Novel primate chitinases and uses therefor
01/08/2009US20090010936 Novel Stra6 Polypeptides